MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $288 | -96.6% | 17,960 | -95.0% | 0.00% | -95.6% |
Q2 2023 | $8,382 | +4609.0% | 361,617 | +2840.0% | 0.07% | +2166.7% |
Q4 2022 | $178 | -100.0% | 12,300 | -47.5% | 0.00% | -40.0% |
Q4 2020 | $463,000 | +10.8% | 23,437 | -36.4% | 0.01% | -54.5% |
Q2 2020 | $418,000 | – | 36,839 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $98,875,000 | 3.47% |
Tieton Capital Management, LLC | 187,636 | $3,711,000 | 2.72% |
Glenview Capital Management | 3,682,691 | $72,825,000 | 1.67% |
Altium Capital Management LP | 218,650 | $4,324,000 | 1.61% |
S&T BANK/PA | 331,098 | $6,547,000 | 1.18% |
EARNEST PARTNERS LLC | 6,731,429 | $133,114,000 | 0.92% |
DISCIPLINED GROWTH INVESTORS INC /MN | 2,078,075 | $41,094,000 | 0.79% |
SummerHaven Investment Management, LLC | 35,700 | $706,000 | 0.55% |
AIMZ Investment Advisors, LLC | 42,685 | $844,000 | 0.44% |
CONTINENTAL ADVISORS LLC | 36,392 | $720,000 | 0.33% |